13 11 20

Information and support

  • Get informed
  • Get support
  • Cut my risk
  • Get involved
  • Research
  • ANZCHOG

    Acronym: 

    ANZCHOG

    ACTRN/NCT /ethics: 

    Scientific title: 

    Summary of trial and patient characteristics

    Cancer Type All cancers
    Trial Type Treatment
    Phase Phase II Tumour Stream Osteosarcoma
    Age Range Paediatric, Adolescent and Young Adult Patients Cancer Stage All stages
    Sex Both Anticipated Start Date
    Molecular Target Anticipated End Date
    Cancer Type All cancers
    Trial Type Treatment
    Phase Phase II
    Age Range Paediatric, Adolescent and Young Adult Patients
    Sex Both
    Molecular Target
    Tumour Stream Osteosarcoma
    Cancer Stage All stages
    Anticipated Start Date
    Anticipated End Date

    Trial Summary

    A phase II study of panobinostat in paediatric, adolescent and young adult patients with solid tumours including osteosarcoma, malignant rhabdoid tumour/ atypical teratoid rhabdoid tumours and neuroblastoma.

    Lay Summary

    Sponsor / Cooperative group

    MSD

    Participating Hospitals

    Hospital Clinical Trial Coordinator Email Phone Principal Investigator Recruitment Status
    Royal Adelaide Hospital Anne Milton anne.milton@sa.gov.au 08 7074 2342 Singhal Not Yet Recruiting